Overview Financials News + Filings Key Docs Charts Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
SUPERNUS PHARMACEUTICALS, INC. (SUPN)
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 10/13/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 10/06/2023 |
4
| DEC TIMOTHY C (Senior Vice-President & CFO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 4,000 options to buy
@ $0 |
|
| 08/25/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 35,000 options to buy
@ $0 |
|
| 08/25/2023 |
4
| Bhatt Padmanabh P. (Sr. VP of IP, CSO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 2,500 options to buy
@ $0 |
|
| 08/21/2023 |
4
| Sensenig Bethany (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 24,153 options to buy
@ $30.22, valued at
$729.9k
|
|
| 05/12/2023 |
4
| DEC TIMOTHY C (Senior Vice-President & CFO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 709 shares
@ $36.47, valued at
$25.9k
Exercised 1,500 options to buy
@ $0 |
|
| 05/12/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 15,005 shares
@ $36.47, valued at
$547.2k
Exercised 31,250 options to buy
@ $0 |
|
| 05/12/2023 |
4
| Bhatt Padmanabh P. (Sr. VP of IP, CSO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Exercised 750 options to buy
@ $0 |
|
| 05/08/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 31,250 options to buy
@ $0 |
|
| 05/08/2023 |
4
| DEC TIMOTHY C (Senior Vice-President & CFO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 1,500 options to buy
@ $0 |
|
| 05/08/2023 |
4
| Bhatt Padmanabh P. (Sr. VP of IP, CSO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 750 options to buy
@ $0 |
|
| 03/16/2023 |
4
| Mottola Frank (Sr VP, Quality, GMP Oper. & IT) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Sold 4,780 shares
@ $35.988, valued at
$172k
|
|
| 02/27/2023 |
4
| Bhatt Padmanabh P. (Sr. VP of IP, CSO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $38.6, valued at
$772k
Granted 5,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Rubin Jonathan (SVP, Chief Medical Officer) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $38.6, valued at
$772k
Granted 5,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| DEC TIMOTHY C (Senior Vice-President & CFO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 40,000 options to buy
@ $38.6, valued at
$1.5M
Granted 10,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $38.6, valued at
$772k
Granted 5,000 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 280,000 options to buy
@ $38.6, valued at
$10.8M
|
|
| 02/27/2023 |
4
| Hudson Frederick M. (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 6,293 options to buy
@ $38.6, valued at
$242.9k
Granted 3,886 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 6,293 options to buy
@ $38.6, valued at
$242.9k
Granted 3,886 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Barlow Carrolee (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 6,293 options to buy
@ $38.6, valued at
$242.9k
Granted 3,886 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 6,293 options to buy
@ $38.6, valued at
$242.9k
Granted 3,886 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 6,293 options to buy
@ $38.6, valued at
$242.9k
Granted 3,886 restricted stock units
@ $0 |
|
| 02/27/2023 |
4
| Mottola Frank (SVP, Quality, GMP, Ops, IT) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 30,000 options to buy
@ $38.6, valued at
$1.2M
Granted 7,500 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| SIEBERT JOHN M (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 3,882 shares
@ $0
Disposed/sold 3,882 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| GEMAYEL GEORGES (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 3,882 shares
@ $0
Disposed/sold 3,882 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| Hudson Frederick M. (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 3,882 shares
@ $0
Disposed/sold 3,882 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| NEWHALL CHARLES W III (Director) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 3,882 shares
@ $0
Disposed/sold 3,882 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| Bhatt Padmanabh P. (Sr. VP of IP, CSO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 750 shares
@ $0
Disposed/sold 750 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| DEC TIMOTHY C (Senior Vice-President & CFO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 500 shares
@ $0
Disposed/sold 500 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| Martin Tami Tillotson (Sr. V.P., Regulatory Affairs) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 750 shares
@ $0
Disposed/sold 750 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| Mottola Frank (SVP, Quality, GMP, Ops, IT) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 750 shares
@ $0
Disposed/sold 750 restricted stock units
@ $0 |
|
| 02/24/2023 |
4
| Rubin Jonathan (SVP, Chief Medical Officer) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 750 shares
@ $0
Disposed/sold 750 restricted stock units
@ $0 |
|
| 02/21/2023 |
4
| Khattar Jack A. (President, CEO) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Granted 20,000 options to buy
@ $0 |
|
| 02/21/2023 |
4
| Mottola Frank (SVP, Quality, GMP, Ops, IT) has filed a Form 4 on SUPERNUS PHARMACEUTICALS, INC.|
Txns:
| Paid exercise price by delivering 753 shares
@ $38.74, valued at
$29.2k
Exercised 1,500 options to buy
@ $0 |
|
|
|
|